Jeffrey Cislini
Senior VP, General Counsel & Corporate SecretaryMr. Jeffrey Cislini, also known as Jeff,J.D., serves as Senior Vice President, General Counsel & Corporate Secretary of Revolution Medicines, Inc. since September 2022 and served as its Vice President, Deputy General Counsel from June 2020 to September 2022. He has experience advising on a wide range of legal topics, including corporate governance, securities law, contracts, compliance, intellectual property, privacy and employment law. He joined Revolution Medicines in 2020 as its deputy general counsel and has served as the company’s senior legal advisor during his tenure. Before joining Revolution Medicines, Mr. Cislini served as a vice president at Atara Biotherapeutics. Mr. Cislini was an attorney at the law firms of O’Melveny & Myers LLP from 2007 to 2018 and Wilson Sonsini Goodrich and Rosati, P.C. from 2001 to 2007. He received a B.A.S. with a double major in Economics and Land Resources Planning from Stanford University and a J.D. from Harvard Law School.
Positions
- Company NameRevolution Medicines, Inc.Stock CodeRVMDPositionSenior VP, General Counsel & Corporate SecretaryRelated SecuritiesColleagues
- MAMark A. GoldsmithCEO, President & Chairman
- JAJack AndersChief Financial Officer
- MAMargaret A. HornChief Operating Officer
- SMStephen M. KelseySenior Advisor
- MDMartin D. BurkeCo-Founder & Chairman of Scientific Advisory Board
- MAMichael A. FischbachAcademic Co-Founder & Member of Scientific Advisory Board
- KMKevan M. ShokatAcademic Co-Founder & Member of Scientific Advisory Board
- EMElizabeth McKee AndersonIndependent Director
